ARCHIVES

Patenting the Gene: Cancer Advocates and Industry Diverge on Myriad Ruling

This article is from The Cancer Letter archive.

Vol. 39 No. 24 | June 14, 2013

Download PDF Visit The Full Archive

Related Articles

Novel Four Drug Combination Safe For Lung Cancer Therapy

November 28, 2008

NCI advisory Group, Other Cancer Meetings

March 29, 1985

NCAB Discussion Of Working Group Report

February 28, 2003

Seer Places Survival Now at Least At 45 Percent, Could Be As High As 50 Percent For 1973-79 Patients

December 4, 1981

Spending Bill Expected At White House Any Day Now; NIH Awaits 15% Increase.

October 27, 2000

Three Organizations Publish Guideline For Biomarker Testing for Targeted Therapies

April 26, 2013